High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$17.3M
$17,291,026
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
2026-02-17
$13,105,233MEGAx3
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
|
2026-02-17 | $13,105,233MEGAx3 | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
2025-10-17
$4,185,793Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
|
2025-10-17 | $4,185,793Large | S | Form 4 |